GENINCODE PLC Logo

GENINCODE PLC

GENI | IL

Overview

Corporate Details

ISIN(s):
GB00BL97B504
LEI:
213800UX6TE7K65O2892
Country:
United Kingdom
Address:
ONE, ST. PETERS SQUARE, M2 3DE MANCHESTER
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

GENINCODE PLC is a company specializing in the genetic risk assessment of cardiovascular disease (CVD). Leveraging over 15 years of research in cardiovascular genomics, the company develops and provides advanced diagnostic tests for physicians globally. Its technology combines clinical algorithms, artificial intelligence (AI), and both monogenic and polygenic risk assessment to analyze a patient's genomic profile, lifestyle, and other clinical risk factors. The resulting tools provide a comprehensive patient risk assessment, enabling the prediction and prevention of cardiovascular disease through personalized healthcare and informed treatment decisions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for GENINCODE PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 08:00
Earnings Release
Trading update
English 15.7 KB
2025-07-07 08:00
Regulatory News Service
De Novo Update – FDA Supervisory Review
English 18.4 KB
2025-06-30 12:42
Post-Annual General Meeting Information
Result of AGM
English 11.1 KB
2025-06-04 08:00
Annual Report
Final Results
English 606.0 KB
2025-05-16 08:00
Report Publication Announcement
Notice of Results
English 18.4 KB
2025-03-26 08:45
Director's Dealing
Grant of Share Options & PDMR Dealings
English 57.5 KB
2025-03-06 15:24
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-03-05 16:02
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-03-04 14:16
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-03-03 13:54
Declaration of Voting Results & Voting Rights Announcements
Result of General Meeting, Issue of Equity and TVR
English 20.5 KB
2025-02-18 08:00
Share Issue/Capital Change
Result of Retail Offer
English 17.6 KB
2025-02-14 11:01
Share Issue/Capital Change
Result of Placing and Subscription
English 32.8 KB
2025-02-14 08:05
Share Issue/Capital Change
Retail Offer
English 35.8 KB
2025-02-14 08:00
Pre-Annual General Meeting Information
Placing and Subscription
English 178.5 KB
2025-01-23 08:00
Regulatory News Service
CARDIO inCode Lab Fee Update & Catalonia Launch
English 20.4 KB

Automate Your Workflow. Get a real-time feed of all GENINCODE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENINCODE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
Gabather AB Logo
Clinical-stage pharma developing GABAA therapeutics for neuropsychiatric disorders.
Sweden GABA
GEIGER COUNTER LIMITED Logo Jersey GCL
Geneuro Logo
Develops HERV-targeting treatments for neurodegenerative and autoimmune diseases.
Switzerland GEM
GENFIT Logo
Biopharma firm developing therapies & diagnostics for rare and severe liver diseases.
France GNFT
GENFLOW BIOSCIENCES PLC Logo
Developing gene therapies to target the aging process in humans and dogs.
United Kingdom GENF